ARCHIVES

“Clinical research of all kinds in the IRP lacks a rigorous, centralized process for peer review.”

This article is from The Cancer Letter archive.

Vol. 21 No. 29 | July 21, 1995

Download PDF Visit The Full Archive

Related Articles

Obituary: Joseph Burchenal, 93, A Leader In Cancer Drug Development at MSKCC.

March 17, 2006

In Brief: Henderson Names to HHA Post; Nurses Support Cigarette Tax Increase; FDA Staff Changes

May 7, 1993

Conversation with The Cancer Letter: IU’s Loehrer Discusses “Business Decision” To Close Bloomington Proton Beam Center

October 17, 2014

Paul Goss, Patricia Ganz Discuss Breast Cancer Prevention Trials.

April 20, 2007

FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine

June 16, 1989

In Brief: Jack White Resigns As Director Of Howard Cancer Center; Roberson to Retire From Centers Program

June 1, 1984